3 of Wall Street's Favorite Stocks We Think Twice About [Yahoo! Finance]
NeoGenomics, Inc. (NEO)
Last neogenomics, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.neogenomics.com
Company Research
Source: Yahoo! Finance
However, it's worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover. Unlike the investment banks, we created StockStory to provide independent analysis that helps you determine which companies are truly worth following. That said, here are three stocks where Wall Street's enthusiasm may be misplaced and some other investments worth exploring instead. nCino (NCNO) Consensus Price Target: $24 (45.6% implied return) Born from the internal technology needs of a community bank in 2011, nCino (NASDAQ:NCNO) provides cloud-based software that helps financial institutions streamline client onboarding, loan origination, and account opening processes. Why Are We Wary of NCNO? Customers had second thoughts about committing to its platform over the last year as its average billings growth of 10.2% underwhelmed Estimated sales growth of 7.9% for the next 12 months implies demand will slow from
Show less
Read more
Impact Snapshot
Event Time:
NEO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NEO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NEO alerts
High impacting NeoGenomics, Inc. news events
Weekly update
A roundup of the hottest topics
NEO
News
- 2 High-Flying Stocks to Consider Right Now and 1 That Underwhelm [Yahoo! Finance]Yahoo! Finance
- NeoGenomics (NEO) Launches RaDaR ST to Capture Share in $20B MRD Market [Yahoo! Finance]Yahoo! Finance
- NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know [Yahoo! Finance]Yahoo! Finance
- NeoGenomics (NEO) had its "buy" rating reaffirmed by TD Cowen.MarketBeat
- NeoGenomics (NEO) had its "market perform" rating reaffirmed by William Blair.MarketBeat
NEO
Earnings
- 2/17/26 - Beat
NEO
Sec Filings
- 3/27/26 - Form SCHEDULE
- 3/3/26 - Form 4
- 3/3/26 - Form 4
- NEO's page on the SEC website